However, MDA-MB-231 breast cancer cells also had 76.6% CD44+CD24−/low cells, indicating that the CD44+CD24−/low subpopulation may encompass stem cells with self-renewal and other cell types without this property (29). Here, CD44 is linked to breast carcinoma.